mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.04 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.093 |
0.04 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.04 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |